ATM and cancer: Cell lines derived from patients with ataxia-telangiectasia and from engineered ATM knockout human or mouse models are sensitive to DNA-damaging agents [12] and PARP inhibitors, raising the possibility that cancers with a functional loss of ATM could be particularly sensitive to these agents [17,18,19,20].